Biosimilars Training Course: Prepare for Growth as Some of the World's Best-known Biologics Face Patent Expiration in the Coming Years (ONLINE EVENT)
June 20, 2024 04:55 ET
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars Training Course" conference has been added to ResearchAndMarkets.com's offering. Prepare for the biosimilar market growth as some of the...
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
June 14, 2024 03:00 ET
|
Samsung Bioepis
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congre
Global Biosimilar Contract Manufacturing Market Forecast 2024-2034 | A Projected $48.67 Billion Opportunity with Profiles of 10+ Leading Market Players | Oncology Applications in North America Dominate
June 05, 2024 03:36 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimilar Contract Manufacturing Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The...
Global Biosimilars and Follow-On Biologics Market Report 2024-2034 - Expanding the Portfolio of Biosimilars for Rare Diseases
May 31, 2024 06:46 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars and Follow-On Biologics Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Biosimilars and...
Biopharmaceuticals Contract Manufacturing Global Market Report 2024
May 21, 2024 04:01 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Contract Manufacturing Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The biopharmaceuticals...
Global Biobetters Market Analysis to 2034 by Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region, Featuring Exhaustive Profiles of the Top 10+ Players
April 09, 2024 11:54 ET
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region" report has been...
Lyophilization Services for Biopharmaceuticals Global Report 2024, Featuring Profiles of Strides Pharma Science, Baxter, Catalent Pharma Solutions, W. L. Gore & Associates and Emergent BioSolutions
April 09, 2024 11:28 ET
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Lyophilization Services for Biopharmaceuticals Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The...
US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030: A $1.28 Trillion Opportunity, Driven by the Rising Adoption of AI-based Tools for Drug Discovery
March 27, 2024 08:34 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product...
Global Bevacizumab Biosimilars Market Outlook 2024-2028 & 2033 Featuring Cipla, Reliance Lifesciences, Genentech, Fujifilm Kyowa Kirin Biologics, and Pfizer
March 06, 2024 07:30 ET
|
Research and Markets
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Bevacizumab Biosimilars Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The bevacizumab biosimilars market has...
Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market
February 23, 2024 13:50 ET
|
Spherix Global Insights
EXTON, PA, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Amidst the array of advanced treatment avenues available for rheumatoid arthritis (RA), ranging from legacy TNF inhibitors and their newer biosimilar...